Related Experiment Video
Updated: Aug 9, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
Fungal infections in patients undergoing blood and marrow transplantation
1Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. Kmarr@fhcrc.org
Abstract:
Fungal infections are currently a leading cause of infectious morbidity and mortality in patients undergoing allogeneic blood and marrow transplantation (BMT). Although the introduction of azole antifungals for prophylaxis has had a significant impact on the incidence of candidal infections (especially those caused by C. albicans and C. tropicalis), invasive aspergillosis has increased in incidence in many centers worldwide. Given the long risk period corresponding with graft-versus-host disease, and the toxicities of currently available mold-active antifungals, the development of a prevention strategy for these angioinvasive molds remains a challenge. The introduction of new antifungal drugs and adjunctive therapy to improve immune function may be beneficial in decreasing mortality associated with these infections in the future. Most importantly, a greater understanding of the pathogenesis of fungal disease and specific host risks is necessary to impact this increasingly important infection in immunocompromised hosts.
Insights
Fungal infections pose a significant threat to patients undergoing blood and marrow transplantation (BMT). Developing effective prevention strategies for invasive fungal infections, particularly invasive aspergillosis, remains a critical challenge.
Area of Science:
- Mycology
- Transplantation Medicine
- Infectious Diseases
Background:
- Fungal infections are a major cause of illness and death in allogeneic blood and marrow transplantation (BMT) patients.
- While azoles reduced Candida infections, invasive aspergillosis has risen, posing a challenge due to long risk periods and toxic antifungal treatments.
- Effective prevention of angioinvasive mold infections in immunocompromised hosts is crucial.
Purpose of the Study:
- To highlight the challenges in preventing fungal infections post-BMT.
- To emphasize the need for improved strategies against invasive aspergillosis.
- To underscore the importance of understanding fungal pathogenesis and host risk factors.
Main Methods:
- Literature review on fungal infections in BMT.
- Analysis of current antifungal prophylaxis and treatment limitations.
- Discussion of emerging therapeutic approaches and research needs.
Main Results:
- Azole antifungals have decreased Candida infections but not invasive aspergillosis.
- Current mold-active antifungals have toxicities, complicating prophylaxis.
- A significant unmet need exists for effective prevention of angioinvasive mold infections.
Conclusions:
- New antifungal drugs and immune-boosting therapies are needed to reduce mortality.
- A deeper understanding of fungal disease mechanisms and host susceptibility is essential.
- Addressing fungal infections in BMT requires multifaceted strategies including improved prevention and treatment.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Fungal Phylum Microsporidia
Cryptococcal Meningitis

